Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-09 Purchase | 2024-09-11 5:47 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 140,000 | $2.8222 | $395,115 | 384,024 (Direct) | View |
2024-01-29 Purchase | 2024-01-31 6:29 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 100,000 | $3.8674 | $386,738 | 244,024 (Direct) | View |
2022-12-08 Purchase | 2022-12-12 8:00 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 55,250 | $2.096 | $115,804 | 144,024 (Direct) | View |
2022-06-30 Sale | 2022-07-05 4:30 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 29,767 | $18.8 | $559,577 | 102,529 (Direct) | View |
2021-03-09 Sale | 2021-03-11 5:51 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 10,000 | $35.48 | $354,845 | 187,985 (Direct) | View |
2021-02-24 Sale | 2021-02-26 4:50 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 10,000 | $34.24 | $342,392 | 197,985 (Direct) | View |
2021-02-11 Sale | 2021-02-16 5:10 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 1,446 | $35.43 | $51,238 | 207,985 (Direct) | View |
2021-02-08 Sale | 2021-02-10 7:25 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 11,206 | $35.17 | $394,085 | 209,431 (Direct) | View |
2021-02-02 Sale | 2021-02-04 5:40 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 3,278 | $35.07 | $114,970 | 234,018 (Direct) | View |
2021-01-27 Sale | 2021-01-29 5:22 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 10,000 | $32.39 | $323,914 | 223,915 (Direct) | View |
2021-01-22 Sale | 2021-01-26 7:29 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 4,070 | $35.43 | $144,180 | 233,915 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-24 Option Award | 2024-05-29 9:25 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 122,358 | $0 | 490,120 (Direct) | View |
2024-05-24 Other | 2024-05-29 9:25 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 122,358 | $0 | 490,120 (Direct) | View |
2023-12-15 Option Award | 2023-12-19 5:28 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 183,881 | $0 | 183,881 (Direct) | View |
2023-05-25 Option Award | 2023-05-30 5:10 pm | 2022-12-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 527,211 | $0 | 850,728 (Direct) | View |
2021-07-08 Ownership(A) | 2023-02-06 5:39 pm | N/A 2022-07-10 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 351,985 | $0 | 777,934 (Direct) | View |
2021-07-08 Ownership | 2023-02-02 5:01 pm | N/A 2022-07-10 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 351,985 | $0 | 552,934 (Direct) | View |
2022-12-16 Other | 2022-12-20 7:31 pm | N/A 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 300,000 | $0 | 0 (Direct) | View |
2022-12-16 Option Award | 2022-12-20 5:34 pm | 2022-12-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 323,517 | $0 | 323,517 (Direct) | View |
2022-06-30 Exercise | 2022-07-05 4:30 pm | 2012-07-10 2022-07-10 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 29,767 | $0 | 102,529 (Direct) | View |
2022-06-30 Exercise | 2022-07-05 4:30 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 29,767 | $16 | 102,529 (Direct) | View |
2022-05-25 Option Award | 2022-05-26 6:45 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 951,821 | $0 | 1,443,994 (Direct) | View |
2021-12-17 Option Award | 2021-12-21 9:31 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 492,173 | $0 | 492,173 (Direct) | View |
2021-03-09 Exercise | 2021-03-11 5:51 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 10,000 | $0 | 187,985 (Direct) | View |
2021-03-09 Exercise | 2021-03-11 5:51 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 10,000 | $3.24 | 187,985 (Direct) | View |
2021-02-24 Exercise | 2021-02-26 4:50 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 10,000 | $0 | 197,985 (Direct) | View |
2021-02-24 Exercise | 2021-02-26 4:50 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 10,000 | $3.24 | 197,985 (Direct) | View |
2021-02-11 Exercise | 2021-02-16 5:10 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 1,446 | $0 | 207,985 (Direct) | View |
2021-02-11 Exercise | 2021-02-16 5:10 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 1,446 | $3.24 | 207,985 (Direct) | View |
2021-02-08 Exercise | 2021-02-10 7:25 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 11,206 | $0 | 209,431 (Direct) | View |
2021-02-08 Exercise | 2021-02-10 7:25 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 11,206 | $3.24 | 209,431 (Direct) | View |
2021-02-02 Exercise | 2021-02-04 5:42 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 13,281 | $0 | 220,637 (Direct) | View |
2021-02-02 Exercise | 2021-02-04 5:42 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 13,281 | $3.24 | 220,637 (Direct) | View |
2021-02-02 Exercise | 2021-02-04 5:40 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 3,278 | $0 | 234,018 (Direct) | View |
2021-02-02 Exercise | 2021-02-04 5:40 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 3,278 | $3.24 | 234,018 (Direct) | View |
2021-01-27 Exercise | 2021-01-29 5:22 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 10,000 | $0 | 223,915 (Direct) | View |
2021-01-27 Exercise | 2021-01-29 5:22 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 10,000 | $3.24 | 223,915 (Direct) | View |
2021-01-22 Exercise | 2021-01-26 7:29 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 4,070 | $0 | 233,915 (Direct) | View |
2021-01-22 Exercise | 2021-01-26 7:29 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 4,070 | $3.24 | 233,915 (Direct) | View |
2021-01-07 Option Award | 2021-01-11 4:05 pm | 2021-04-07 2031-01-07 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 500,000 | $0 | 500,000 (Direct) | View |
2020-08-18 Exercise | 2020-08-19 4:15 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 50,008 | $0 | 237,985 (Direct) | View |
2020-08-18 Tax Withholding | 2020-08-19 4:15 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 4,151 | $39.03 | 237,985 (Direct) | View |
2020-08-18 Exercise | 2020-08-19 4:15 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 50,008 | $3.24 | 237,985 (Direct) | View |
2019-12-19 Option Award | 2019-12-23 4:58 pm | N/A 2029-12-19 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 350,000 | $43.47 | 350,000 (Direct) | View |